ePRO/eCOA White Papers & Case Studies
-
CRO Uses CRIO eSource To Double Monitoring Productivity
1/31/2025
Examine the transformative impact of eSource technology on monitoring productivity during a global Phase 3 trial conducted by a Contract Research Organization (CRO) amid the COVID-19 pandemic.
-
Using Virtual Study Coordinators For EDC Entry And Query Resolution To Speed Up Data Access And Cleaning
1/31/2025
The piece showcases how the effective use of CRIO can significantly enhance site performance, supporting recruitment and diversity objectives for sponsors.
-
Partnership Driving Superior Enrollment And Speed In Phase III Trial
1/31/2025
Examine the partnership between CRIO and Sitero, including how it underscores the significant impact of technology in optimizing trial performance and accelerating treatment development.
-
Proving The Return On Investment For eRegulatory
1/22/2025
A study of how leading research centers, CROs, and sponsors cover the cost of eRegulatory tools... and then some.
-
Overcoming Issues Of Non-Enrolling Sites In Clinical Trials
1/14/2025
Explore the challenges of non-enrolling sites in clinical trials, focusing on the benefits of leveraging artificial intelligence (AI) and machine learning (ML) in addressing those issues.
-
Rave EDC: Trusted For Decades. Leading Today. Innovating For Tomorrow
1/13/2025
Explore an EDC platform designed to simplify clinical trials, offering single sign-on, real-time data validation, and drag-and-drop eCRF creation.
-
Rave Lite For Phase IV Trials
1/13/2025
Designed for post-marketing surveillance and observational studies, Medidata’s Rave EDC offers a tailored and scalable solution for Phase IV and late-stage trials.
-
Breaking Free From Process Paralysis In Clinical Trials
1/13/2025
Explore the implementation of CRIO’s eSource solution by a leading pharmaceutical company to overcome process paralysis in clinical research.
-
How Syneos Health Tackles Protocol Complexities
1/7/2025
Explore solutions employed by Syneos Health, a global contract research organization, to optimize Phase IIV clinical trials, particularly under a complex adaptive trial protocol.
-
How eSource Reduced Benchmark's Protocol Deviations By Almost 40%
1/6/2025
Explore how a leading vaccine site network selected CRIO to help address the challenges with it's use of paper charts in collecting source data.